1 year return (CAGR)
-85.01%
Neumora Therapeutics, Inc. Exchange (NASDAQ, USD)
NMRA
0.39
-0.00 (-1.20%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-66.98%
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
72.96M
Price/Sales
-
Ent value
36.86M
Price/Book
1.64
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
17.29%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.40 |
| Daily high | 0.41 |
| Daily low | 0.37 |
| Daily Volume | 1.38M |
| All-time high | 19.76 |
| 1y analyst estimate | 6.14 |
| Beta | 2.74 |
| EPS (TTM) | -1.15 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NMRA | S&P500 | |
| Current price drop from All-time high | -98.03% | -1.25% |
| Highest price drop | -98.20% | -56.47% |
| Date of highest drop | 14 Oct 2026 | 9 Mar 2009 |
| Avg drop from high | -67.21% | -10.65% |
| Avg time to new high | 98 days | 12 days |
| Max time to new high | 678 days | 1805 days |
News
